Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29676| Title: | Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: Final 5 year efficacy and safety results from a phase 3 trial | Authors: | Mease, Philip J. Kavanaugh, Arthur Reimold, Andreas Tahir, Hasan Rech, Juergen Hall, Stephen GEUSENS, Piet Pellet, Pascale Delicha, Eumorphia Maria Pricop, Luminita Mpofu, Shephard |
Issue Date: | 2019 | Publisher: | BMJ PUBLISHING GROUP | Source: | ANNALS OF THE RHEUMATIC DISEASES, 78, p. 917-917 (Art N° FRI0451) | Notes: | [Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA. [Mease, Philip J.] Univ Washington, Seattle, WA 98195 USA. [Kavanaugh, Arthur] Univ Calif San Diego, Sch Med, La Jolla, CA USA. [Reimold, Andreas] Dallas VA Med Ctr, Dallas, TX USA. [Reimold, Andreas] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA. [Tahir, Hasan] Barts Hlth NHS Trust, London, England. [Rech, Juergen] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Erlangen, Germany. [Hall, Stephen] Monash Univ, Melbourne, Vic, Australia. [Geusens, Piet] Univ Hasselt, Hasselt, Belgium. [Geusens, Piet] Maastricht Univ Hosp, Maastricht, Netherlands. [Pellet, Pascale; Delicha, Eumorphia Maria; Mpofu, Shephard] Novartis Pharma AG, Basel, Switzerland. [Pricop, Luminita] Novartis Pharmaceut, E Hanover, NJ USA. | Keywords: | Rheumatology | Document URI: | http://hdl.handle.net/1942/29676 | ISSN: | 0003-4967 | e-ISSN: | 1468-2060 | DOI: | 10.1136/annrheumdis-2019-eular.2768 | ISI #: | 000472207102496 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| mease 1.pdf Restricted Access | Published version | 50.18 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.